Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

What’s Next For SpaceX

Published

on

Barron's

The IPO is done. Trading has begun. The SpaceX drama, however, is just beginning.

SpaceX completed its record-setting IPO on Thursday, and it closed just under $161 on Friday, up 19% from the $135 IPO price, valuing Musk’s rocket company at $2.1 trillion.

Now investors have to brace for SpaceX to be included in the Nasdaq 100 inclusion, which should happen in two weeks. That will drive $7 billion to $10 billion in buying. After that, the company will release its first quarterly earnings report, likely in July. That will be an event unto itself. After that, some shares will start to come off lockup, increasing the number of shares available to trade.

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Nara Organics infant formula recalled after 3 babies get botulism

Published

on

Nara Organics infant formula recalled after 3 babies get botulism

Federal health officials are urging parents to immediately stop using a popular organic infant formula after three babies were hospitalized with botulism in a multistate outbreak linked to the product.

The Centers for Disease Control and Prevention said all three infants consumed Nara Organics Whole Milk Organic Infant Formula before becoming ill.

Advertisement

The babies, who ranged in age from 2 to 5 months, were hospitalized and treated with BabyBIG, the FDA-approved treatment for infant botulism.

The cases were reported in California, Pennsylvania and Washington, according to the CDC.

POPULAR PET FOOD BRAND HALTS PRODUCTION AFTER FDA WARNS OF POSSIBLE DANGEROUS CONTAMINATION

Nara Organics Whole Milk Organic Infant Formula container

Federal health officials are urging parents to stop using Nara Organics Whole Milk Organic Infant Formula after three infants were hospitalized with botulism. (Food and Drug Administration / Unknown)

Nara Organics on Friday recalled all lots and can sizes of its Whole Milk Organic Infant Formula, and federal health officials are investigating whether the product was the source of the outbreak.

Advertisement

Testing of opened and unopened formula samples is underway, with results expected in the coming weeks.

Nara Organics confirmed the recall in a statement posted on its website.

THREE MAJOR HOSPITAL SYSTEMS ACCUSE CVS OF SECRETLY SIPHONING HUNDREDS OF MILLIONS IN DRUG SAVINGS

CDC Sign

Three infants were hospitalized with botulism in a multistate outbreak linked to recalled Nara Organics infant formula, according to the CDC. (Nathan Posner/Anadolu Agency via Getty Images / Getty Images)

“Stop using all Nara Organics infant formula immediately,” the company wrote. “We are heartbroken for the concern and stress this may cause your family.”

Advertisement

The formula is sold nationwide through Target stores, Target.com and Nara.com.

The CDC advised parents and caregivers to throw away or return any unopened cans of the recalled formula.

FDA ISSUES HIGHEST-RISK RECALL FOR ALFREDO SAUCE SOLD IN 41 STATES

Baby drinks from milk bottle

Three infants ranging in age from 2 to 5 months were hospitalized after consuming the recalled formula, federal health officials said. (iStock / iStock)

Officials said opened cans may be retained and stored separately if an infant develops symptoms, as state health departments may request samples for testing.

Advertisement

According to the CDC, infant botulism occurs when spores from Clostridium botulinum bacteria enter a baby’s digestive tract and produce a dangerous toxin.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Early symptoms can include constipation, difficulty feeding, a weak or altered cry and loss of head control.

Parents should seek immediate medical attention if an infant who consumed the recalled formula develops symptoms including poor feeding, difficulty swallowing, decreased facial expression or loss of head control, health officials said.

Advertisement
Continue Reading

Business

Brookfield Is Buying the Rest of Oaktree Capital for $3 Billion to Build a Cash Machine

Published

on

Brookfield Is Buying the Rest of Oaktree Capital for $3 Billion to Build a Cash Machine

Business partnerships can try men’s souls—never mind the wallets of those who invest in them. So far, though, the tie-up between super-investors Bruce Flatt, CEO of Brookfield, and Howard Marks, co-chairman of Oaktree Capital Management, seems to be mostly friction-free and fruitful.

Continue Reading

Business

Analysts Report on Zscaler and Four More Stocks

Published

on

Take-Two, Mondelez Get Analyst Attention

These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or recommendations of Barron’s. Some of the reports’ issuers have provided, or hope to provide, investment-banking or other services to the companies being analyzed.

Continue Reading

Business

SpaceX Blasts Off Without a Hitch

Published

on

Spencer Jakab hedcut

SpaceX’s IPO saw shares soar 19% Friday, with the rocket-maker ending its first day as the sixth-most valuable public company in the U.S. An army of individual investors bought into Elon Musk’s vision of putting data centers in space to support the rise of AI.

Continue Reading

Business

Aurinia Pharmaceuticals and Four More Stocks See Activist Action

Published

on

Pearson, Appian, WEX, and More Stocks See Action From Activist Investors

Aurinia Pharmaceuticals and Four More Stocks See Activist Action

Continue Reading

Business

Sports Betting Is Ancient History

Published

on

Robotics Could Be a Boon for the Elderly

Sports Betting Is Ancient History

Continue Reading

Business

Eli Lilly: The Macro Health Crisis Is Still Undervalued

Published

on

Eli Lilly: The Macro Health Crisis Is Still Undervalued

Eli Lilly: The Macro Health Crisis Is Still Undervalued

Continue Reading

Business

SpaceX, Now Worth $2.1 Trillion, Pulls Off Goldilocks Debut

Published

on

SpaceX, Now Worth $2.1 Trillion, Pulls Off Goldilocks Debut

Shares in SpaceX SPCX 19.22%increase; up pointing triangle soared 19% Friday as Elon Musk’s rocket maker pulled off the largest initial public offering ever and one of the smoothest in recent history.

The company, valued at $1.77 trillion when it sold $75 billion worth of shares a day earlier, ended its first day of trading with a market value of $2.1 trillion, putting it ahead of Broadcom and Tesla to make it the sixth-most valuable public company in the U.S.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading

Business

David James backs affordable football kit charities

Published

on

David James backs affordable football kit charities

The former England goalie does not want costly kit to be a bar to anyone hoping to play football.

Continue Reading

Business

Will the Magnificent Seven Give Way to the Dirty Dozen?

Published

on

Barron's

Will the Magnificent Seven Give Way to the Dirty Dozen?

Continue Reading

Trending

Copyright © 2025